(Northwestern University) The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2yxTnNH
No comments:
Post a Comment